Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10.6M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
741K
-
Shares change
-
+212K
-
Total reported value, excl. options
-
$4.5M
-
Value change
-
+$1.27M
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$6.08
Significant Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q4 2020
12 filings reported holding ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 741K shares
of 10.6M outstanding shares and own 6.98% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (347K shares), VANGUARD GROUP INC (147K shares), Minot Wealth Management LLC (132K shares), Worth Venture Partners, LLC (87.9K shares), BlackRock Inc. (23.7K shares), CITIGROUP INC (750 shares), Tower Research Capital LLC (TRC) (653 shares), FEDERATED HERMES, INC. (472 shares), UBS Group AG (454 shares), and WELLS FARGO & COMPANY/MN (300 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.